as on February 28, 2026 at 7:59 am IST
Day's Low
23.53%
Downside
52 Week's Low
52 Week's High
52.35%
Downside
8.24%
Upside
Check Pmv Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$59.6M
EPS (TTM)
-1.515
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-91.4M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-51.87%
Compare market cap, revenue, PE, and other key metrics of Pmv Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $59.6M | -96.36% | NA | 0.00% | |
| BUY | $43.4B | 123.66% | 141.1 | 8.45% | |
| BUY | $122.7B | 125.89% | 31.55 | 32.94% | |
| NA | $39.0B | NA | 664.59 | 1.38% | |
| BUY | $82.9B | 71.07% | 18.9 | 31.41% |
The Pmv Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Pmv Pharmaceuticals Inc investment value today
Current value as on today
₹1,24,744
Returns
₹24,744
(+24.74%)
Returns from Pmv Pharmaceuticals Inc Stock
₹20,567 (+20.57%)
Dollar Returns*
₹4,177 (+4.18%)
Based on 12 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Pmv Pharmaceuticals Inc. Average target price of $7.6
Get share price movements and forecasts by analysts on Pmv Pharmaceuticals Inc.
What analysts predicted
77.63%UPSIDE
Target Price
$7.6
Current Price
$1.7
Analyzed by
12 Analysts
Target
$7.60
Pmv Pharmaceuticals Inc target price $7.6, a slight upside of 77.63% compared to current price of $1.7. According to 12 analysts rating.
Search interest for Pmv Pharmaceuticals Inc Stock has increased by 23% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:23% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, PMVP stock has moved up by 31.7%
Against Peers
![]()
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 39.7% return, outperforming this stock by 42.5%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 74.3% return, outperforming this stock by 155.5%
| Organisation | Pmv Pharmaceuticals Inc |
| Headquarters | 400 Alexander Park Drive, Princeton, NJ, United States, 08540 |
| Industry | Commercial Services |
| CEO | Dr. David H. Mack Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Michael Carulli | Chief Financial Officer |
Mr. Robert Ticktin J.D. | General Counsel, COO & Company Secretary |
Ms. Crystal Zuckerman | Vice President of Human Resources |
Ms. Laura De Leon | VP & Head of Clinical Operations |
Dr. David H. Mack Ph.D. | Co-Founder, CEO, President & Director |
Dr. Arnold J. Levine Ph.D. | Co-Founder, Independent Director & Member of Scientific Advisory Board |
Dr. Deepika Jalota Pharm.D. | Chief Development Officer |
Mr. Tim Smith M.B.A. | Senior VP and Head of Corporate Development & Investor Relations |
Dr. Binh Vu Ph.D. | Senior Vice President of Drug Discovery & CMC |
Dr. Marc Fellous M.D. | Senior VP and Head of Clinical Development & Medical Affairs |
Pmv Pharmaceuticals Inc share price today is $1.7 as on at the close of the market. Pmv Pharmaceuticals Inc share today touched a day high of $1.7 and a low of $1.3.
Pmv Pharmaceuticals Inc share touched a 52 week high of $1.84 on and a 52 week low of $0.81 on . Pmv Pharmaceuticals Inc stock price today i.e. is closed at $1.7,which is 7.61% down from its 52 week high and 109.88% up from its 52 week low.
Pmv Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Pmv Pharmaceuticals Inc (PMVP) shares with as little as ₹90.988 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹909.88 in Pmv Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Pmv Pharmaceuticals Inc share’s latest price of $1.7 as on February 28, 2026 at 2:29 am IST, you will get 5.8824 shares of Pmv Pharmaceuticals Inc. Learn more about
fractional shares .
Pmv Pharmaceuticals Inc stock has given -96.36% share price returns and 23.86% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?